June 17, 2022
Imagine being told you’ll have to self-inject a medication – without instructions – that has only been FDA approved for provider-administration. Chances are, you may not use it at all, even though it means inviting dangerous symptoms.
April 11, 2022
By Brenda Young - Wonder if a storm is coming? “Ask Brenda’s lungs,” my friends suggest.
January 4, 2022
Health economists have put a damper on asthma patients’ hopes for better disease management in 2022.
November 4, 2021
By James M. Tracy, DO - With every new treatment option, physicians have a better chance of getting it right for each individual patient.
October 15, 2021
ICER’s priorities differ from severe asthma patients’, and the economists’ approach could make it harder for patients to access the…
October 12, 2021
Just as asthma impacts people differently, existing treatment options serve some patients better than others.
July 9, 2021
The admonition to the Institute for Clinical and Economic Review’s Beacon Hill economists should be quite simple: “Stay in your lane.”
May 25, 2021
Most people have never heard of pharmacy benefit managers, the businesses that negotiate prescription drug coverage for health insurers. But they could play an outsized – and unwelcome – role in treatment decisions.
April 23, 2021
This could be a life-changing year for chronic respiratory patients.
March 2, 2021
More patients than ever before are making their doctor’s appointments. What’s helping them? Telehealth.